CRC cells have higher basal β-catenin/Tcf activity than prostate cancer cells, where the TOP/FOP ratio is below 1, while it is around 10 in HCT116 cells and 2–3 in HT29 cells ([27] insert ref as above). Here, HNF4A is linked to prostate carcinoma.